Market Cap | ₹339Cr |
ROE | 7.74% |
P/E Ratio(TTM) | 45.26 |
EPS(TTM) | 2.10 |
P/B Ratio | 3.28 |
Dividend Yield | 0.00% |
Industry P/E | 33.86 |
Book Value | 29.01 |
Debt to Equity | 0.38 |
Face Value | 10 |
Parent Organisation | Lyka Labs |
Managing Director | Mr. Kunal Gandhi |
NSE Symbol | LYKALABS |
COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
---|---|---|---|---|
Cohance Lifesciences | NA (0.00%) | 100.21 | ||
JB Chemicals & Pharmaceuticals | NA (0.00%) | 38.19 | ||
Emcure Pharmaceuticals | NA (0.00%) | 32.70 | ||
Wockhardt | NA (0.00%) | -176.41 |